+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

EU5 Reproductive Health Diagnostics Market Outlook to 2033 - Prenatal Screening and Reproductive Hormones and Proteins Tests

  • PDF Icon

    Report

  • 124 Pages
  • July 2025
  • Region: Europe
  • GlobalData
  • ID: 6115324
The “EU5 Reproductive Health Diagnostics Market Outlook to 2033” is a comprehensive databook report, covering key market data on the EU5 Reproductive Health Diagnostics market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Prenatal Screening and Reproductive Hormones and Proteins Tests

The EU5 Reproductive Health Diagnostics Market report provides key information and data on:

  • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
  • 2024 company share data for Reproductive Health Diagnostics Market.
  • Global corporate-level profiles of key companies operating within the EU5 Reproductive Health Diagnostics Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

EU5 Reproductive Health Diagnostics is segmented as follows:

  • Prenatal Screening
  • Reproductive Hormones and Proteins Tests

Reasons to Buy

The EU5 Reproductive Health Diagnostics Market report helps you to develop:

  • Business strategies by identifying the key market segments poised for strong growth in the future.
  • Market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Reproductive Health Diagnostics Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Reproductive Health Diagnostics Market, EU5
3.1 Reproductive Health Diagnostics Market, EU5, Revenue ($m), 2018-2033
3.2 Reproductive Health Diagnostics Market, EU5, Revenue ($m), 2018-2033
3.3 Reproductive Health Diagnostics Market, EU5, Volume (Units), 2018-2033
3.4 Reproductive Health Diagnostics Market, EU5, Volume (Units), 2018-2033
3.5 Reproductive Health Diagnostics Market, EU5, Company Share by Revenue ($m), 2024
4 Reproductive Health Diagnostics Market, Germany
4.1 Reproductive Health Diagnostics Market, Germany, Revenue ($m), 2018-2033
4.1.1 Prenatal Screening Market, Germany, Revenue ($m), by Segment, 2018-2033
4.1.2 Reproductive Hormones and Proteins Tests Market, Germany, Revenue ($m), by Segment, 2018-2033
4.2 Reproductive Health Diagnostics Market, Germany, Volume (Units), 2018-2033
4.2.1 Prenatal Screening Market, Germany, Volume (Units), by Segment, 2018-2033
4.2.2 Reproductive Hormones and Proteins Tests Market, Germany, Volume (Units), by Segment, 2018-2033
4.3 Reproductive Health Diagnostics Market, Germany, Average Price ($), 2018-2033
4.4 Reproductive Health Diagnostics Market, Germany, Company Share by Revenue ($m), 2024
5 Reproductive Health Diagnostics Market, United Kingdom
5.1 Reproductive Health Diagnostics Market, United Kingdom, Revenue ($m), 2018-2033
5.1.1 Prenatal Screening Market, United Kingdom, Revenue ($m), by Segment, 2018-2033
5.1.2 Reproductive Hormones and Proteins Tests Market, United Kingdom, Revenue ($m), by Segment, 2018-2033
5.2 Reproductive Health Diagnostics Market, United Kingdom, Volume (Units), 2018-2033
5.2.1 Prenatal Screening Market, United Kingdom, Volume (Units), by Segment, 2018-2033
5.2.2 Reproductive Hormones and Proteins Tests Market, United Kingdom, Volume (Units), by Segment, 2018-2033
5.3 Reproductive Health Diagnostics Market, United Kingdom, Average Price ($), 2018-2033
5.4 Reproductive Health Diagnostics Market, United Kingdom, Company Share by Revenue ($m), 2024
6 Reproductive Health Diagnostics Market, France
6.1 Reproductive Health Diagnostics Market, France, Revenue ($m), 2018-2033
6.1.1 Prenatal Screening Market, France, Revenue ($m), by Segment, 2018-2033
6.1.2 Reproductive Hormones and Proteins Tests Market, France, Revenue ($m), by Segment, 2018-2033
6.2 Reproductive Health Diagnostics Market, France, Volume (Units), 2018-2033
6.2.1 Prenatal Screening Market, France, Volume (Units), by Segment, 2018-2033
6.2.2 Reproductive Hormones and Proteins Tests Market, France, Volume (Units), by Segment, 2018-2033
6.3 Reproductive Health Diagnostics Market, France, Average Price ($), 2018-2033
6.4 Reproductive Health Diagnostics Market, France, Company Share by Revenue ($m), 2024
7 Reproductive Health Diagnostics Market, Italy
7.1 Reproductive Health Diagnostics Market, Italy, Revenue ($m), 2018-2033
7.1.1 Prenatal Screening Market, Italy, Revenue ($m), by Segment, 2018-2033
7.1.2 Reproductive Hormones and Proteins Tests Market, Italy, Revenue ($m), by Segment, 2018-2033
7.2 Reproductive Health Diagnostics Market, Italy, Volume (Units), 2018-2033
7.2.1 Prenatal Screening Market, Italy, Volume (Units), by Segment, 2018-2033
7.2.2 Reproductive Hormones and Proteins Tests Market, Italy, Volume (Units), by Segment, 2018-2033
7.3 Reproductive Health Diagnostics Market, Italy, Average Price ($), 2018-2033
7.4 Reproductive Health Diagnostics Market, Italy, Company Share by Revenue ($m), 2024
8 Reproductive Health Diagnostics Market, Spain
8.1 Reproductive Health Diagnostics Market, Spain, Revenue ($m), 2018-2033
8.1.1 Prenatal Screening Market, Spain, Revenue ($m), by Segment, 2018-2033
8.1.2 Reproductive Hormones and Proteins Tests Market, Spain, Revenue ($m), by Segment, 2018-2033
8.2 Reproductive Health Diagnostics Market, Spain, Volume (Units), 2018-2033
8.2.1 Prenatal Screening Market, Spain, Volume (Units), by Segment, 2018-2033
8.2.2 Reproductive Hormones and Proteins Tests Market, Spain, Volume (Units), by Segment, 2018-2033
8.3 Reproductive Health Diagnostics Market, Spain, Average Price ($), 2018-2033
8.4 Reproductive Health Diagnostics Market, Spain, Company Share by Revenue ($m), 2024
9 Overview of Key Companies in EU5 Reproductive Health Diagnostics Market
9.1 Illumina Inc
9.1.1 Company Overview
9.2 Danaher Corp
9.2.1 Company Overview
9.3 Eurofins Scientific SE
9.3.1 Company Overview
9.4 F. Hoffmann-La Roche Ltd
9.4.1 Company Overview
9.5 Quidelortho Corp
9.5.1 Company Overview
9.6 Siemens AG
9.6.1 Company Overview
9.7 Abbott Laboratories
9.7.1 Company Overview
10 Reproductive Health Diagnostics Market Pipeline Products
11 Appendix
11.1 Research Methodology
11.1.1 Coverage
11.1.2 Secondary Research
11.1.3 Primary Research
11.1.4 Market Modeling and Forecasting
11.1.5 Company Share Analysis
11.1.6 Benchmarking
11.2 the analyst Consulting
11.3 Contact the Publisher
11.4 Disclaimer
List of Tables
Table 1: Reproductive Health Diagnostics Market, Cross Country Comparison, EU5, Revenue ($m), USD Constant, 2018-2033
Table 2: Reproductive Health Diagnostics Market, EU5, Revenue ($m), USD Constant, 2018-2033
Table 3: Reproductive Health Diagnostics Market, EU5, Volume (Units), 2018-2033
Table 4: Reproductive Health Diagnostics Market, EU5, Volume (Units), 2018-2033
Table 5: Reproductive Health Diagnostics Market, EU5, Company Share by Revenue ($m), 2024
Table 6: Reproductive Health Diagnostics Market, Germany, Revenue ($m), USD Constant, 2018-2033
Table 7: Prenatal Screening Market, Germany, Revenue ($m), USD Constant, 2018-2033
Table 8: Reproductive Hormones and Proteins Tests Market, Germany, Revenue ($m), USD Constant, 2018-2033
Table 9: Reproductive Health Diagnostics Market, Germany, Volume (Units), 2018-2033
Table 10: Prenatal Screening Market, Germany, Volume (Units), 2018-2033
Table 11: Reproductive Hormones and Proteins Tests Market, Germany, Volume (Units), 2018-2033
Table 12: Reproductive Health Diagnostics Market, Germany, Average Price ($), 2018-2033
Table 13: Reproductive Health Diagnostics Market, Germany, Company Share by Revenue ($m), 2024
Table 14: Reproductive Health Diagnostics Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Table 15: Prenatal Screening Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Table 16: Reproductive Hormones and Proteins Tests Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Table 17: Reproductive Health Diagnostics Market, United Kingdom, Volume (Units), 2018-2033
Table 18: Prenatal Screening Market, United Kingdom, Volume (Units), 2018-2033
Table 19: Reproductive Hormones and Proteins Tests Market, United Kingdom, Volume (Units), 2018-2033
Table 20: Reproductive Health Diagnostics Market, United Kingdom, Average Price ($), 2018-2033
Table 21: Reproductive Health Diagnostics Market, United Kingdom, Company Share by Revenue ($m), 2024
Table 22: Reproductive Health Diagnostics Market, France, Revenue ($m), USD Constant, 2018-2033
Table 23: Prenatal Screening Market, France, Revenue ($m), USD Constant, 2018-2033
Table 24: Reproductive Hormones and Proteins Tests Market, France, Revenue ($m), USD Constant, 2018-2033
Table 25: Reproductive Health Diagnostics Market, France, Volume (Units), 2018-2033
Table 26: Prenatal Screening Market, France, Volume (Units), 2018-2033
Table 27: Reproductive Hormones and Proteins Tests Market, France, Volume (Units), 2018-2033
Table 28: Reproductive Health Diagnostics Market, France, Average Price ($), 2018-2033
Table 29: Reproductive Health Diagnostics Market, France, Company Share by Revenue ($m), 2024
Table 30: Reproductive Health Diagnostics Market, Italy, Revenue ($m), USD Constant, 2018-2033
Table 31: Prenatal Screening Market, Italy, Revenue ($m), USD Constant, 2018-2033
Table 32: Reproductive Hormones and Proteins Tests Market, Italy, Revenue ($m), USD Constant, 2018-2033
Table 33: Reproductive Health Diagnostics Market, Italy, Volume (Units), 2018-2033
Table 34: Prenatal Screening Market, Italy, Volume (Units), 2018-2033
Table 35: Reproductive Hormones and Proteins Tests Market, Italy, Volume (Units), 2018-2033
Table 36: Reproductive Health Diagnostics Market, Italy, Average Price ($), 2018-2033
Table 37: Reproductive Health Diagnostics Market, Italy, Company Share by Revenue ($m), 2024
Table 38: Reproductive Health Diagnostics Market, Spain, Revenue ($m), USD Constant, 2018-2033
Table 39: Prenatal Screening Market, Spain, Revenue ($m), USD Constant, 2018-2033
Table 40: Reproductive Hormones and Proteins Tests Market, Spain, Revenue ($m), USD Constant, 2018-2033
Table 41: Reproductive Health Diagnostics Market, Spain, Volume (Units), 2018-2033
Table 42: Prenatal Screening Market, Spain, Volume (Units), 2018-2033
Table 43: Reproductive Hormones and Proteins Tests Market, Spain, Volume (Units), 2018-2033
Table 44: Reproductive Health Diagnostics Market, Spain, Average Price ($), 2018-2033
Table 45: Reproductive Health Diagnostics Market, Spain, Company Share by Revenue ($m), 2024
Table 46: Reproductive Health Diagnostics Market Pipeline Products
Table 47: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country
List of Figures
Figure 1: Reproductive Health Diagnostics Market, Cross Country Comparison, EU5, Revenue ($m), USD Constant, 2018-2033
Figure 2: Reproductive Health Diagnostics Market, EU5, Revenue ($m), USD Constant, 2018-2033
Figure 3: Reproductive Health Diagnostics Market, EU5, Volume (Units), 2018-2033
Figure 4: Reproductive Health Diagnostics Market, EU5, Volume (Units), 2018-2033
Figure 5: Reproductive Health Diagnostics Market, EU5, Company Share (%), 2024
Figure 6: Reproductive Health Diagnostics Market, Germany, Revenue ($m), USD Constant, 2018-2033
Figure 7: Prenatal Screening Market, Germany, Revenue ($m), USD Constant, 2018-2033
Figure 8: Reproductive Hormones and Proteins Tests Market, Germany, Revenue ($m), USD Constant, 2018-2033
Figure 9: Reproductive Health Diagnostics Market, Germany, Volume (Units), 2018-2033
Figure 10: Prenatal Screening Market, Germany, Volume (Units), 2018-2033
Figure 11: Reproductive Hormones and Proteins Tests Market, Germany, Volume (Units), 2018-2033
Figure 12: Reproductive Health Diagnostics Market, Germany, Company Share (%), 2024
Figure 13: Reproductive Health Diagnostics Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Figure 14: Prenatal Screening Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Figure 15: Reproductive Hormones and Proteins Tests Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Figure 16: Reproductive Health Diagnostics Market, United Kingdom, Volume (Units), 2018-2033
Figure 17: Prenatal Screening Market, United Kingdom, Volume (Units), 2018-2033
Figure 18: Reproductive Hormones and Proteins Tests Market, United Kingdom, Volume (Units), 2018-2033
Figure 19: Reproductive Health Diagnostics Market, United Kingdom, Company Share (%), 2024
Figure 20: Reproductive Health Diagnostics Market, France, Revenue ($m), USD Constant, 2018-2033
Figure 21: Prenatal Screening Market, France, Revenue ($m), USD Constant, 2018-2033
Figure 22: Reproductive Hormones and Proteins Tests Market, France, Revenue ($m), USD Constant, 2018-2033
Figure 23: Reproductive Health Diagnostics Market, France, Volume (Units), 2018-2033
Figure 24: Prenatal Screening Market, France, Volume (Units), 2018-2033
Figure 25: Reproductive Hormones and Proteins Tests Market, France, Volume (Units), 2018-2033
Figure 26: Reproductive Health Diagnostics Market, France, Company Share (%), 2024
Figure 27: Reproductive Health Diagnostics Market, Italy, Revenue ($m), USD Constant, 2018-2033
Figure 28: Prenatal Screening Market, Italy, Revenue ($m), USD Constant, 2018-2033
Figure 29: Reproductive Hormones and Proteins Tests Market, Italy, Revenue ($m), USD Constant, 2018-2033
Figure 30: Reproductive Health Diagnostics Market, Italy, Volume (Units), 2018-2033
Figure 31: Prenatal Screening Market, Italy, Volume (Units), 2018-2033
Figure 32: Reproductive Hormones and Proteins Tests Market, Italy, Volume (Units), 2018-2033
Figure 33: Reproductive Health Diagnostics Market, Italy, Company Share (%), 2024
Figure 34: Reproductive Health Diagnostics Market, Spain, Revenue ($m), USD Constant, 2018-2033
Figure 35: Prenatal Screening Market, Spain, Revenue ($m), USD Constant, 2018-2033
Figure 36: Reproductive Hormones and Proteins Tests Market, Spain, Revenue ($m), USD Constant, 2018-2033
Figure 37: Reproductive Health Diagnostics Market, Spain, Volume (Units), 2018-2033
Figure 38: Prenatal Screening Market, Spain, Volume (Units), 2018-2033
Figure 39: Reproductive Hormones and Proteins Tests Market, Spain, Volume (Units), 2018-2033
Figure 40: Reproductive Health Diagnostics Market, Spain, Company Share (%), 2024

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • Agilent Technologies Inc
  • Beckman Coulter Inc
  • BGI Genomics Co Ltd
  • Danaher Corp
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche Ltd
  • Illumina Inc
  • Ortho Clinical Diagnostics Holdings Plc